Trial intelligence / Profile preview

ICAT: Intracoronary Abciximab and Aspiration Thrombectomy in STEMI

NCT01404507Phase 4Completed

Sponsor
Yonsei University
Start
Dec 2010
Primary completion
Feb 2012
Modality
Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of abciximab in ST elevation myocardial infarction (STEMI), sponsored by Yonsei University. Started Dec 2010; status: completed.

02

Drugs

abciximab
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT01404507.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01404507.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call